Navigation Links
Microban International Announces Breakthrough in Antimicrobial Technologies for Medical Devices
Date:12/16/2010

HUNTERSVILLE, N.C., Dec. 16, 2010 /PRNewswire/ -- Hospital Acquired Infections (HAI's) are a serious health threat associated with over 100,000 deaths each year.  These secondary infections following surgery are a major contributor to increased healthcare costs; experts estimate they add in excess of $20 billion.

Microban International is leveraging its expertise in antimicrobial technologies for polymers to look for synergistic effects to help medical device manufacturers address bacterial contamination of medical devices commonly associated with HAI's.  "Our experience with a broad range of antimicrobial technologies and materials puts us in a unique position to be able to help medical device manufacturers get to market more quickly with more effective technologies," said Dr. Ivan Ong, VP of Research and Development for Microban International.

The company has recently made significant advances in the development of antimicrobial solutions for acetal (POM), a material commonly used in catheter tubing and connector components which can be a source of HAI's.  Acetals are prone to processing issues with many additives, causing chemical degradation and formaldehyde off-gassing in the final product.  A new antimicrobial solution has been developed that is compatible with acetal and causes no destabilization or formaldehyde generation.  Our findings show effective performance with greater than 4 log reductions against a wide variety of organisms using our standard, enhanced and human-serum based testing protocols.  "This new work is a significant step forward and will help medical device manufacturers to offer an antimicrobial solution that is more robust and provides more consistent antimicrobial performance," said Dr. Ong.  

Microban provides comprehensive development support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  For more information please visit http://www.microban.com/microban-medical.

Contact: Cady Warner, (704) 875-0806


'/>"/>
SOURCE Microban International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Ischemic Stroke Market ... to their offering.       (Logo: ... Global Acute Ischemic Stroke Market and Competitive ... Acute Ischemic Stroke pipeline products, Acute Ischemic ...
(Date:5/3/2016)... KANSAS CITY, Mo. , May 3, 2016 ... of Kansas Medical Center,s Institute for Advancing Medical ... develop and commercialize new drugs, diagnostics and medical ... organizations provides BioNovus Innovations with rights to license, ... "This partnership ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... Somnoware Healthcare Systems ... announced it has secured $9 million in Series A funding led by TransLink ... will be used by Somnoware to further fulfill its mission to connect, organize ...
(Date:5/4/2016)... ... May 04, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Quaker Ridge Golf Club in Scarsdale, New York on May 23, 2016 for ...
(Date:5/4/2016)... Palm City, Florida (PRWEB) , ... May 04, ... ... providers of cold therapy products, announced today the introduction of the innovative newly ... for post operative hip replacement patients. The plush design enhances comfort and enables ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... The ... Day to recognize chaplains for their valuable support to patients and their families, and ... May 10. , To mark Spiritual Care Day, SCA has sent “Thank You Chaplain” ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy (CAET) ... promotion, time saving and planning tools to attendees and exhibitors for the 2016 ...
Breaking Medicine News(10 mins):